Biotech startup AviadoBio emerges with $80M for neuro disorder gene therapies December 3, 2021 Auto Bot BioPharma, deals, gene therapy, investing, London, neurodegenerative diseases, Pharma, Startups 0 AviadoBio’s gene therapies are designed to achieve widespread distribution throughout the central nervous system. The company’s lead program on track to begin human testing as a treatment for frontotemporal dementia.